Engineered for accuracy — trusted for research.
-
BPC-157 is a synthetic pentadecapeptide fragment derived from gastric protein studies.
- Extensively explored in pre-clinical research for its potential influence on angiogenesis, cell migration, and tissue modeling.
- Independently verified for purity and identity through Vanguard Laboratory.
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide isolated from gastric juice proteins and has been investigated for its role in vascular and soft-tissue recovery models.
Pre-clinical findings suggest activation of VEGFR2 → Akt/eNOS signaling pathways supporting endothelial integrity and angiogenesis
Studies in rodent models have explored effects on muscle-to-bone reattachment and tendon repair interfaces
Regulatory Status: BPC-157 is not FDA-approved for human or veterinary use and is provided strictly for laboratory research.